Condition

Other Solid Tumours (2)

Bladder Cancer (1)

Cholangiocarcinoma (1)

Endometrial Cancer (1)

Gastric Cancer (1)

Glioma (1)

Sarcoma (1)

Squamous Non-small Cell Lung Cancer (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Celon Pharma SA (1)

Laminar Pharmaceuticals (1)

Collaborator

Instituto Oncologico IMQ, Clinica IMQ Zorrotzaurre. Bilbao (1)

National Center for Research and Development, Poland (1)

Northern Institute for Cancer Research, Newcastle (1)

Onkologikoa, San Sebastian. (1)

Royal Marsden NHS Foundation Trust (1)

Specialized Medical Services (SMS)-Oncology BV (1)

Vall d'Hebron Institute of Oncology (1)

Intervention

2-hydroxyoleic acid (2-ohoa/2ohoa) (1)

cpl304110 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

other solid tumours

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gastric Cancer, Bladder Cancer, Squamous NSCLC Trial in Poland (CPL304110)

Recruiting

Gastric Cancer
+6 more

CPL304110

Gdańsk, Poland
+6 more

Mar 9, 2022

Glioma, Other Solid Tumours Trial in Spain, United Kingdom (2-hydroxyoleic acid (2-OHOA/2OHOA))

Completed

Glioma
Other Solid Tumours

2-hydroxyoleic acid (2-OHOA/2OHOA)

Barcelona, Spain
+4 more

Dec 5, 2016